{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:25:32Z","timestamp":1790526332622,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.hoc.2020.05.002","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T17:37:08Z","timestamp":1595439428000},"page":"795-807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Molecular Pathogenesis of Mantle Cell Lymphoma"],"prefix":"10.1016","volume":"34","author":[{"given":"Alba","family":"Navarro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Be\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Jares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u00edas","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"40","key":"10.1016\/j.hoc.2020.05.002_bib1","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1038\/sj.onc.1204640","article-title":"Mechanisms of chromosomal translocations in B cell lymphomas","volume":"20","author":"Kuppers","year":"2001","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.hoc.2020.05.002_bib2","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1182\/blood-2006-08-039859","article-title":"Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival","volume":"109","author":"Wiestner","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2020.05.002_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ccr.2010.08.012","article-title":"Nuclear cyclin D1\/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase","volume":"18","author":"Aggarwal","year":"2010","journal-title":"Cancer Cell"},{"issue":"7279","key":"10.1016\/j.hoc.2020.05.002_bib4","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nature08684","article-title":"Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen","volume":"463","author":"Bienvenu","year":"2010","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.hoc.2020.05.002_bib5","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1158\/0008-5472.CAN-11-3549","article-title":"Proteomic identification of a direct role for cyclin d1 in DNA damage repair","volume":"72","author":"Jirawatnotai","year":"2012","journal-title":"Cancer Res"},{"issue":"30","key":"10.1016\/j.hoc.2020.05.002_bib6","doi-asserted-by":"crossref","first-page":"12461","DOI":"10.1073\/pnas.1018941108","article-title":"A\u00a0cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma","volume":"108","author":"Beltran","year":"2011","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"9","key":"10.1016\/j.hoc.2020.05.002_bib7","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1172\/JCI96520","article-title":"Cyclin D1 overexpression induces global transcriptional downregulation in lymphoid neoplasms","volume":"128","author":"Albero","year":"2018","journal-title":"J\u00a0Clin Invest"},{"issue":"10","key":"10.1016\/j.hoc.2020.05.002_bib8","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/sj.leu.2403459","article-title":"Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma","volume":"18","author":"Wlodarska","year":"2004","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.hoc.2020.05.002_bib9","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1080\/10428194.2018.1427863","article-title":"Mantle Cell Lymphoma with t(11;22) (q13;q11.2) an indolent clinical variant?","volume":"59","author":"Marrero","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"10.1016\/j.hoc.2020.05.002_bib10","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1182\/bloodadvances.2019031450","article-title":"Characterization of a cryptic IGH\/CCND1 rearrangement in a case of mantle cell lymphoma with negative CCND1 FISH studies","volume":"3","author":"Peterson","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.hoc.2020.05.002_bib11","article-title":"Cryptic insertions of the immunoglobulin light chain enhancer region near CCND1 in t(11;14)-negative mantle cell lymphoma","author":"Fuster","year":"2019","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.hoc.2020.05.002_bib12","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.3324\/haematol.2018.208140","article-title":"Cryptic insertion of MYC exons 2 and 3 into the IGH locus detected by whole genome sequencing in a case of MYC-negative Burkitt lymphoma","volume":"105","author":"Wagener","year":"2020","journal-title":"Haematologica"},{"issue":"18","key":"10.1016\/j.hoc.2020.05.002_bib13","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1182\/blood.2019002600","article-title":"The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH","volume":"134","author":"Hilton","year":"2019","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.hoc.2020.05.002_bib14","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood-2013-01-475954","article-title":"Cyclin D1-negative mantle cell lymphoma","volume":"121","author":"Seto","year":"2013","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.hoc.2020.05.002_bib15","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2012-08-452284","article-title":"CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma","volume":"121","author":"Salaverria","year":"2013","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.hoc.2020.05.002_bib16","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","article-title":"Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling","volume":"106","author":"Fu","year":"2005","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.hoc.2020.05.002_bib17","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","article-title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype","volume":"94","author":"Mozos","year":"2009","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.hoc.2020.05.002_bib18","doi-asserted-by":"crossref","first-page":"e432","DOI":"10.3324\/haematol.2018.192435","article-title":"t(11;14)-positive mantle cell lymphomas lacking cyclin D1 (CCND1) immunostaining because of a CCND1 mutation or exclusive expression of the CCND1b isoform","volume":"103","author":"Iaccarino","year":"2018","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.hoc.2020.05.002_bib19","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood-2018-07-862151","article-title":"CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1(-) mantle cell lymphoma","volume":"133","author":"Martin-Garcia","year":"2019","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2020.05.002_bib20","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/leu.2015.355","article-title":"SOX11 defines two different subtypes of mantle cell lymphoma through transcriptional regulation of BCL6","volume":"30","author":"Palomero","year":"2016","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.hoc.2020.05.002_bib21","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1182\/blood-2012-06-438937","article-title":"SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma","volume":"121","author":"Vegliante","year":"2013","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.hoc.2020.05.002_bib22","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1182\/blood-2018-02-832535","article-title":"SOX11 augments BCR signaling to drive MCL-like tumor development","volume":"131","author":"Kuo","year":"2018","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.hoc.2020.05.002_bib23","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1182\/blood-2014-04-569566","article-title":"SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma","volume":"124","author":"Palomero","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2020.05.002_bib24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2017-04-776740","article-title":"SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma","volume":"130","author":"Balsas","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2020.05.002_bib25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3324\/haematol.2017.177162","article-title":"Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment","volume":"103","author":"Rudelius","year":"2018","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.hoc.2020.05.002_bib26","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ccell.2016.09.014","article-title":"Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage","volume":"30","author":"Queiros","year":"2016","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.hoc.2020.05.002_bib27","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1172\/JCI61272","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"122","author":"Jares","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"20","key":"10.1016\/j.hoc.2020.05.002_bib28","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-12-1615","article-title":"Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features","volume":"72","author":"Navarro","year":"2012","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.hoc.2020.05.002_bib29","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fernandez","year":"2010","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.hoc.2020.05.002_bib30","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1182\/blood-2007-06-093401","article-title":"Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma","volume":"111","author":"Ek","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2020.05.002_bib31","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1158\/1078-0432.CCR-13-1077","article-title":"Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry","volume":"20","author":"Espinet","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.hoc.2020.05.002_bib32","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1200\/JCO.2008.19.6121","article-title":"Outcome of deferred initial therapy in mantle-cell lymphoma","volume":"27","author":"Martin","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.hoc.2020.05.002_bib33","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","article-title":"A\u00a0subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease","volume":"101","author":"Orchard","year":"2003","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.hoc.2020.05.002_bib34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/leu.2012.72","article-title":"Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease","volume":"26","author":"Royo","year":"2012","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.hoc.2020.05.002_bib35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood-2018-03-838136","article-title":"A\u00a0gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome","volume":"132","author":"Clot","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2020.05.002_bib36","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/leu.2009.31","article-title":"(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals","volume":"23","author":"Lecluse","year":"2009","journal-title":"Leukemia"},{"issue":"27","key":"10.1016\/j.hoc.2020.05.002_bib37","first-page":"459","article-title":"Mantle cell lymphoma 12 years after allogeneic bone marrow transplantation occurring simultaneously in recipient and donor","volume":"28","author":"Christian","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2020.05.002_bib38","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3324\/haematol.2011.052621","article-title":"In situ mantle cell lymphoma: Clinical implications of an incidental finding with indolent clinical behavior","volume":"97","author":"Carvajal-Cuenca","year":"2012","journal-title":"Haematologica"},{"issue":"20","key":"10.1016\/j.hoc.2020.05.002_bib39","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2020.05.002_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2013.08.003","article-title":"Monoclonal B cell lymphocytosis and \u201cin situ\u201d lymphoma","volume":"24","author":"Karube","year":"2014","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"10.1016\/j.hoc.2020.05.002_bib41","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.hoc.2020.05.002_bib42","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1158\/0008-5472.CAN-04-1526","article-title":"CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a\/ARF locus","volume":"65","author":"Hernandez","year":"2005","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.hoc.2020.05.002_bib43","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1158\/2159-8290.CD-14-0098","article-title":"Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma","volume":"4","author":"Chiron","year":"2014","journal-title":"Cancer Discov"},{"issue":"12","key":"10.1016\/j.hoc.2020.05.002_bib44","first-page":"4365","article-title":"Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants","volume":"93","author":"Bea","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2020.05.002_bib45","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1200\/JCO.2015.63.8387","article-title":"Prognostic value of Ki-67 index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the european mantle cell lymphoma network","volume":"34","author":"Hoster","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.hoc.2020.05.002_bib46","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1182\/blood-2006-11-057208","article-title":"Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis","volume":"109","author":"Pinyol","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2020.05.002_bib47","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/PAS.0000000000000758","article-title":"Mantle cell lymphoma with MYC rearrangement: a report of 17 patients","volume":"41","author":"Hu","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.hoc.2020.05.002_bib48","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1182\/blood-2010-01-263806","article-title":"Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling","volume":"116","author":"Hartmann","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2020.05.002_bib49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"issue":"15","key":"10.1016\/j.hoc.2020.05.002_bib50","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1200\/JCO.2016.70.7901","article-title":"New molecular assay for the proliferation signature in mantle cell lymphoma applicable to formalin-fixed paraffin-embedded biopsies","volume":"35","author":"Scott","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.hoc.2020.05.002_bib51","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1200\/JCO.2006.08.4251","article-title":"Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature","volume":"25","author":"Salaverria","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2020.05.002_bib52","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.V99.1.238","article-title":"ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances","volume":"99","author":"Camacho","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2020.05.002_bib53","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/sj.leu.2403571","article-title":"Checkpoint kinase 1 (CHK1) protein and mRNA expression is downregulated in aggressive variants of human lymphoid neoplasms","volume":"19","author":"Tort","year":"2005","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.hoc.2020.05.002_bib54","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1182\/blood-2015-02-628792","article-title":"High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma","volume":"126","author":"Delfau-Larue","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2020.05.002_bib55","article-title":"KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study","author":"Ferrero","year":"2019","journal-title":"Haematologica"},{"issue":"17","key":"10.1016\/j.hoc.2020.05.002_bib56","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2017-04-779736","article-title":"TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy","volume":"130","author":"Eskelund","year":"2017","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.hoc.2020.05.002_bib57","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1182\/blood-2008-07-170183","article-title":"Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling","volume":"113","author":"Bea","year":"2009","journal-title":"Blood"},{"issue":"45","key":"10.1016\/j.hoc.2020.05.002_bib58","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.1073\/pnas.1314608110","article-title":"Landscape of somatic mutations and clonal evolution in mantle cell lymphoma","volume":"110","author":"Bea","year":"2013","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"9","key":"10.1016\/j.hoc.2020.05.002_bib59","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1182\/blood-2011-11-391474","article-title":"Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma","volume":"119","author":"Kridel","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2020.05.002_bib60","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","article-title":"The canonical Notch signaling pathway: unfolding the activation mechanism","volume":"137","author":"Kopan","year":"2009","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.hoc.2020.05.002_bib61","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s13046-019-1458-7","article-title":"Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy","volume":"38","author":"Silkenstedt","year":"2019","journal-title":"J\u00a0Exp Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.hoc.2020.05.002_bib62","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1182\/blood-2011-03-343434","article-title":"Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases","volume":"118","author":"Hadzidimitriou","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.hoc.2020.05.002_bib63","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/bjh.15108","article-title":"Ibrutinib resistance in mantle cell lymphoma: clinical, molecular and treatment aspects","volume":"181","author":"Hershkovitz-Rokah","year":"2018","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.hoc.2020.05.002_bib64","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma","volume":"369","author":"Wang","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.hoc.2020.05.002_bib65","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3324\/haematol.2017.184325","article-title":"A\u00a0B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial","volume":"103","author":"Bomben","year":"2018","journal-title":"Haematologica"},{"issue":"18","key":"10.1016\/j.hoc.2020.05.002_bib66","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1158\/1078-0432.CCR-08-3215","article-title":"Phosphatidylinositol 3\u2019-kinase catalytic subunit alpha gene amplification contributes to the pathogenesis of mantle cell lymphoma","volume":"15","author":"Psyrri","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.hoc.2020.05.002_bib67","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13045-018-0621-5","article-title":"NF-kappaB signaling and its relevance to the treatment of mantle cell lymphoma","volume":"11","author":"Balaji","year":"2018","journal-title":"J\u00a0Hematol Oncol"},{"issue":"12","key":"10.1016\/j.hoc.2020.05.002_bib68","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/blood-2008-12-194852","article-title":"TNFAIP3\/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas","volume":"114","author":"Honma","year":"2009","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.hoc.2020.05.002_bib69","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1182\/blood-2016-03-704528","article-title":"Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma","volume":"128","author":"Mansouri","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2020.05.002_bib70","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4049\/jimmunol.171.1.88","article-title":"Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis","volume":"171","author":"Pham","year":"2003","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.hoc.2020.05.002_bib71","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.4049\/jimmunol.178.3.1923","article-title":"Selective inhibition of IkappaB kinase sensitizes mantle cell lymphoma B cells to TRAIL by decreasing cellular FLIP level","volume":"178","author":"Roue","year":"2007","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.hoc.2020.05.002_bib72","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/his.13935","article-title":"Increased tumour angiogenesis in SOX11-positive mantle cell lymphoma","volume":"75","author":"Petrakis","year":"2019","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.hoc.2020.05.002_bib73","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/leu.2013.204","article-title":"Point mutation E1099K in MMSET\/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies","volume":"28","author":"Oyer","year":"2014","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.hoc.2020.05.002_bib74","doi-asserted-by":"crossref","first-page":"e51422","DOI":"10.1371\/journal.pone.0051422","article-title":"Estimation of copy number alterations from exome sequencing data","volume":"7","author":"Valdes-Mas","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.hoc.2020.05.002_bib75","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1158\/2159-8290.CD-18-0083","article-title":"PTEN methylation by NSD2 controls cellular sensitivity to DNA damage","volume":"9","author":"Zhang","year":"2019","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.hoc.2020.05.002_bib76","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41591-018-0243-z","article-title":"Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma","volume":"25","author":"Agarwal","year":"2019","journal-title":"Nat Med"},{"issue":"16","key":"10.1016\/j.hoc.2020.05.002_bib77","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood-2013-01-478834","article-title":"The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma","volume":"121","author":"Meissner","year":"2013","journal-title":"Blood"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858820300629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858820300629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:13:09Z","timestamp":1760184789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858820300629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0889858820300629"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2020.05.002","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Pathogenesis of Mantle Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2020.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}